PAVmed (PAVM) Operating Income (QoQ) (2016 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | PAVmed | 4.15 Mn | -9.02 Mn | -703,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -40.44% |
| Sep 30, 2025 | -2.74% |
| Jun 30, 2025 | 13.42% |
| Mar 31, 2025 | -4.99% |
| Jun 30, 2024 | 2.51% |
| Mar 31, 2024 | 14.33% |
| Dec 31, 2023 | -5.51% |
| Sep 30, 2023 | 5.80% |
| Jun 30, 2023 | 19.20% |
| Mar 31, 2023 | 17.07% |
| Dec 31, 2022 | -5.28% |
| Sep 30, 2022 | 0.50% |
| Jun 30, 2022 | -19.60% |
| Mar 31, 2022 | 0.22% |
| Dec 31, 2021 | -43.98% |
| Sep 30, 2021 | -5.38% |
| Jun 30, 2021 | -60.58% |
| Mar 31, 2021 | -6.90% |
| Dec 31, 2020 | -36.69% |
| Sep 30, 2020 | -10.25% |
| Jun 30, 2020 | 4.55% |
| Mar 31, 2020 | -14.49% |
| Dec 31, 2019 | -41.43% |
| Sep 30, 2019 | 2.26% |
| Jun 30, 2019 | -5.57% |
| Mar 31, 2019 | 5.07% |
| Dec 31, 2018 | -28.93% |
| Sep 30, 2018 | 6.21% |
| Jun 30, 2018 | -40.91% |
| Mar 31, 2018 | -2.93% |
| Dec 31, 2017 | 4.04% |
| Sep 30, 2017 | 2.64% |
| Jun 30, 2017 | 6.25% |
| Mar 31, 2017 | -26.06% |
| Dec 31, 2016 | 11.31% |
| Sep 30, 2016 | -46.70% |
| Jun 30, 2016 | -88.66% |